Research Analysts Set Expectations for BEAM FY2025 Earnings
Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Research analysts at Cantor Fitzgerald decreased their FY2025 earnings per share estimates for Beam Therapeutics in a note issued to investors on Wednesday, February 26th. Cantor Fitzgerald analyst R. Bienkowski now expects that the company will earn ($3.55) per share for the year, down from their previous […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Research analysts at Cantor Fitzgerald decreased their FY2025 earnings per share estimates for Beam Therapeutics in a note issued to investors on Wednesday, February 26th. Cantor Fitzgerald analyst R. Bienkowski now expects that the company will earn ($3.55) per share for the year, down from their previous […]
